NCT02461589 · Interventional trial
Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes
Overall registry status Completed
Phase 2
Conditions Diabetes, Diabetes Mellitus, Type 2
Delaware Valley sites
- Novo Nordisk Investigational Site · Downingtown, PA · Chester County
- Novo Nordisk Investigational Site · Lawrenceville, NJ · Mercer County
- Novo Nordisk Investigational Site · Media, PA · Delaware County
First posted
Registry updated
Added to the directory